Both studies are based on surgically resected lung cancer samples of East Asian populations, in which the frequencies of KRAS and EGFR mutations are reported to be 8–10% and 40–55%, respectively, in lung adenocarcinomas [59]. Here, KRAS is linked to lung adenocarcinoma.